If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 10 of 41
Concept Identification for MEG Aphasia
Objective
Concept Identification for MEG Aphasia
Protocol No
ANES-IIT-GROSS-CONCEPT-ID
Categories
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)
Objective
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults
Protocol No
GIM-DUKE-PREVENTABLE
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
Objective
Registry of Patients with AQP4+ NMOSD Treated with Alexion C5 Inhibitor Therapies
Protocol No
NEURO-ALEXION-ALX-NMO-501
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)
Objective
AR1001 in Participants With Early Alzheimer's Disease
Protocol No
NEURO-ARIBIO-POLARIS-AD
A Prospective, Observational Study of Bafiertam Evaluating Persistence on Treatment, Safety, Tolerability, And Effectiveness In Routine Clinical Practice
Objective
Observational Study of Bafiertam Treatment In Routine Clinical Practice SIMPLE
Protocol No
NEURO-BANNER-SIMPLE
A Multicenter, International, Randomized, Placebo Controlled, Double-Blind, Parallel Group And Event Driven Phase 3 Study Of The Oral Fxia Inhibitor Asundexian (BAY 2433334) For The Prevention Of Ischemic Stroke In Male And Female Participants Aged 1
Objective
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms
Protocol No
NEURO-BAYER-OCEANIC-STROKE
Categories
A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multip
Objective
BIIB091 and BIIB091 Combined with Diroximel Fumarate in Relapsing MS
Protocol No
NEURO-BIOGEN-FUSION
Effectiveness of Switching to Cladribine Tablets in Multiple Sclerosis Patients with High Disease Activity or Disease Breakthrough in a US Real-World Population (HDA Switch Study)
Objective
Cladribine Tablets in MS with High Disease Activity or Disease Breakthrough
Protocol No
NEURO-EMD-HDA-SWITCH
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (Nmdar) Or Anti-Leuci
Objective
Satralizumab in NMDAR or LGI1 Enchephalitis
Protocol No
NEURO-GENENTECH-CIELO
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Objective
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Protocol No
NEURO-IIT-ANDERSON-DIL